Ultra-sensitive detection of rare T cell clones

2011/09/11 by Harlan Robins, Cindy Desmarais, Jessica Matthis +8 · 27 citations
Immunology and Microbiology · Medicine · #T-cell and B-cell Immunology #Immune Cell Function and Interaction #CAR-T cell therapy research

paper · doi:10.1016/j.jim.2011.09.001

Cited by

• RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
• Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
• The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis. [europepmc]
• Adoptive immunotherapy for cancer or viruses. [europepmc]
• Oligoclonal CD8+ T cells play a critical role in the development of hypertension. [europepmc]
• Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. [europepmc]
• Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. [europepmc]
• Common clonal origin of central and resident memory T cells following skin immunization. [europepmc]
• Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. [europepmc]
• Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. [europepmc]
• CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer. [europepmc]
• Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses. [europepmc]
• TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. [europepmc]
• The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy. [europepmc]
• Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. [europepmc]
• The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma. [europepmc]
• Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. [europepmc]
• T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. [europepmc]
• Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. [europepmc]
• CD8 + T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. [europepmc]
• Comprehensive T cell repertoire characterization of non-small cell lung cancer. [europepmc]
• A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma. [europepmc]
• Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c + B cells. [europepmc]
• Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment. [europepmc]
• Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. [europepmc]
• Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial. [europepmc]
• RNA neoantigen vaccines prime long-lived CD8 + T cells in pancreatic cancer. [europepmc]